38 results
8-K
EX-99.1
ALBT
Avalon GloboCare Corp
4 Jan 22
Avalon GloboCare Provides Year-End Business Update of Selective Scientific and Clinical Programs
9:05am
patients.
Avalon’s research partnership with the University of Natural Resources and Life Sciences (BOKU) in Vienna, Austria, is rapidly progressing
8-K
EX-99.1
ALBT
Avalon GloboCare Corp
16 Jun 23
Entry into a Material Definitive Agreement
4:08pm
Emeritus, University of Natural Resources and Life Sciences, Full Member, Austrian Academy of Sciences Scientific & Clinical Advisory Board Management
8-K
EX-99.1
ALBT
Avalon GloboCare Corp
2 May 22
Regulation FD Disclosure
4:00pm
President Uwe B. Sletyr, Ph.D. -- Professor Emeritus, University of Natural Resources and Life Sciences Full Member, Austrian Academy of Sciences
S-8
ALBT
Avalon GloboCare Corp
8 Dec 20
Registration of securities for employees
4:30pm
, multi-target CAR-T, CAR-NK and other immune effector cell therapeutic modalities with Arbele Corp
Strategic partnership with the University of Natural … Resources and Life Sciences (BOKU) in Vienna, Austria to develop an S-layer vaccine that can be administered by an intranasal or oral route against
8-K
EX-10.1
tm6d wf5kow37rb1c8k
23 Dec 16
Entry into a Material Definitive Agreement
12:00am
DEF 14A
9779u
17 Jun 19
Definitive proxy
4:31pm
8-K
EX-2.1
3qfts
14 Jun 21
Avalon GloboCare Announces Execution of Purchase Agreement for Acquisition of SenlangBio in All Stock Transaction
9:12am
DEFA14A
EX-2.1
8s1lpi 0a
14 Jun 21
Additional proxy soliciting materials
9:10am